Arthritis psoriatica: vizsgálatok itt: Franciaország
14 of 22 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisBefejeződöttContinuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- Where
- Chambray Les Tours, Reims Cedex, Saint-Priest-en-Jarez, Toulouse
- Életkor
- 18 év and over
- People
- 1182 worldwide
- Run by
- Takeda
See details and how to joinNCT07286058 · EU 2025-522586-30-00 - 4. fázisNot yet taking people in FranciaországAn open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment
- Where
- Brest, Reims, Toulon Cedex 9, Toulouse
- People
- 339 worldwide
- Run by
- Novartis Pharma AG
See details and how to joinNCT04638647 · EU 2023-504417-67-00 - 2. fázisTaking peopleStudy of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
- Where
- Bordeaux, Caluire-et-Cuire, Chambray-lès-Tours, Nice, Orléans
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- AbbVie
See details and how to joinNCT06865105 - No phaseTaking peopleEfficacy of a Self-Management Smartphone App to Improve Safety Skills in Patients With Inflammatory Arthritis
- Where
- Paris
- Életkor
- 18 év to 75 év
- People
- 144
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07460739 - 3. fázisBefejeződöttA Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
- Where
- Bron, Le Kremlin Bicetre Cedex, Nimes Cedex 9, Paris, Poitiers
- Életkor
- 1 év to 18 év
- People
- 190 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT03773965 · EU 2023-506131-15-00 - 3. fázisTaking peopleA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Where
- Lille Cedex
- Életkor
- 3 év to 64 év
- People
- 196 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00 - 3. fázisTaking peopleAn Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
- Where
- Chambray Les Tours, Le Kremlin Bicetre Cedex, Paris, Poitiers
- Életkor
- 2 év to 18 év
- People
- 40 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT06668181 · EU 2023-508845-41-00 - 3. fázisTaking peopleApremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
- Where
- Bron, Lille Cedex
- Életkor
- 5 év to 17 év
- People
- 60 worldwide
- Run by
- Amgen
See details and how to joinNCT04804553 · EU 2023-503435-17-00 - 3. fázisTaking peopleA Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Where
- Bordeaux, Le Kremlin Bicetre Cedex
- Életkor
- 5 év to 17 év
- People
- 40 worldwide
- Run by
- AbbVie
See details and how to joinNCT06100744 · EU 2023-506026-36-00 - No phaseTaking peopleCytokine Expression in Psoriasis Patients With and Without Joint Involvement
- Where
- Poitiers
- Életkor
- 18 év to 100 év
- People
- 40
- Run by
- Poitiers University Hospital
See details and how to joinNCT05307809 - No phaseTaking peopleHLA B Leader in Patients With Psoriatic Arthritis
- Where
- Amiens
- Életkor
- 18 év and over
- People
- 658
- Run by
- Centre Hospitalier Universitaire, Amiens
See details and how to joinNCT07718815 - No phaseTaking peopleDeployment o the Multidisciplinary Prospective Cohort Imminent
- Where
- Lille
- Életkor
- 18 év and over
- People
- 2200
- Run by
- University Hospital, Lille
See details and how to joinNCT04334031 - 3. fázisNot yet taking people in FranciaországA study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with psoriatic arthritis (PsA)
- Where
- Cahors, Caluire-Et-Cuire, Chambray Les Tours, Echirolles, Montpellier, Narbonne Cedex, Nice, Paris, Rouen Cedex, St Etienne Cedex 2, Toulouse
- Életkor
- 18 év and over
- People
- 948 worldwide
- Run by
- MoonLake Immunotherapeutics AG
See details and how to join2025-522471-28-00 - No phaseTaking peopleInfluence of Sodium Intake in spondyLoarthriTes
- Where
- Besançon, La Roche-sur-Yon, Saint-Etienne, Trévenans
- Életkor
- 18 év to 80 év
- People
- 250
- Run by
- Centre Hospitalier Universitaire de Besancon
See details and how to joinNCT06259890